Lichen Planus Clinical Trial
Official title:
A Double-blind, Randomized, Multi-center Study to Evaluate the Safety and Efficacy of Etanercept 50 mg Twice Weekly Versus Etanercept 25 mg Twice Weekly Versus Placebo in the Treatment of Lichen Planus
This is a research study whose purpose is to test the effectiveness of etanercept (Enbrel) in the treatment of moderate to severe lichen planus. No studies have been done on the effectiveness of etanercept in lichen planus, although etanercept has been tested and used on other medical conditions. Etanercept has not been FDA approved for the treatment of lichen planus.
Lichen planus is a chronic, inflammatory skin disease which can be particularly difficult to
treat. The exact cause of lichen planus is not clear, but a number of studies suggest that
immune system cells called T lymphocytes play a role through abnormally increased activity.
Etanercept is a drug which helps to maintain proper T lymphocyte activity and has been FDA
approved for the treatment of psoriasis, another skin condition known to be caused by T
cells with abnormally increased activity. There is no known cure for lichen planus. We hope
to learn if etanercept represents an effective and safe treatment for lichen planus.
This research study is looking for 64 people with lichen planus. The study will be conducted
at 12 sites across the United States. Approximately 5 subjects will be enrolled at this
site.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06021405 -
Koebner's Phenomenon in Psoriasis and Lichen Planus
|
N/A | |
| Recruiting |
NCT03340155 -
Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases
|
N/A | |
| Completed |
NCT05787925 -
Adjunctive Oral Systemic Vitamin E Therapy on Salivary Nitric Oxide Level in Patients With Erosive Oral Lichen Planus
|
N/A | |
| Completed |
NCT03630198 -
Pain Outcomes Following Intralesional Corticosteroid Injections
|
Phase 4 | |
| Completed |
NCT04952961 -
Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study
|
N/A | |
| Recruiting |
NCT04697563 -
Laser Therapy in Women With Lichenoid Disorders
|
N/A | |
| Recruiting |
NCT06451744 -
Cellular and Molecular Biomarkers in Patients With Lichen Planus
|
N/A | |
| Completed |
NCT03265093 -
Use of Injectable Platelet Rich Fibrin in Lichen Planus
|
N/A | |
| Completed |
NCT03858634 -
A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases
|
Phase 2 | |
| Completed |
NCT02761122 -
Implication of Human Papillomavirus (HPV) in Lichen Physiopathology in Human (HPVLichen)
|
N/A | |
| Terminated |
NCT05761158 -
Study of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus Pilaris
|
||
| Recruiting |
NCT02261662 -
Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection
|
N/A | |
| Not yet recruiting |
NCT04892381 -
Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
|
||
| Completed |
NCT05396261 -
a Flexible Wound Dressing for the Management of Genital Skin Conditions
|
N/A | |
| Recruiting |
NCT02532166 -
Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus
|
N/A | |
| Recruiting |
NCT06327620 -
Treatment Of Oral Lichen Planus
|
N/A | |
| Completed |
NCT03796806 -
Methods Validation Assessment for Study of Inflammatory Skin Disease
|
||
| Completed |
NCT02850601 -
Dexamethasone Solution for the Treatment of Oral Lichen Planus
|
Phase 2 | |
| Not yet recruiting |
NCT01041625 -
Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus
|
Phase 2 | |
| Completed |
NCT00824889 -
Exploratory Study of Natural Killer Cells in Human Skin
|
N/A |